MedPath

A clinical study to evaluate the efficacy of kukkutanda basti in hypoalbuminemia in childhood minimal changes nephrotic syndrome.

Phase 2
Conditions
Health Condition 1: N040- Nephrotic syndrome with minor glomerular abnormality
Registration Number
CTRI/2023/07/054717
Lead Sponsor
Parul Ayurved Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Age group- 3 to 10 years

Diagnosed cases of primary type of nephrotic syndrome (idiopathic) of either the

gender.

The other alternate modern treatment to be continued as per recommended dose

according to allopathy treatment protocol as per the guideline

Children with parents who agree to participate and sign informed consent

Exclusion Criteria

Patients of nephrotic syndrome due to other disorders i.e SLE, drug toxicity, any

genetic disorders.

Patients of nephrotic syndrome associated with illness like cardiovascular disease, tuberculosis, immuno deficiency syndrome, etc.

Advanced or critical phase of nephrotic syndrome which requires immediate intervention like dialysis depending on history and general condition at the point of examination as found by the investigator will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To manage hypoalbuminemia through rectal route without overloading proteinsTimepoint: 14 DAYS
Secondary Outcome Measures
NameTimeMethod
Relief in post hypoalbuminemia symptoms i.e <br/ ><br>1.Secondary oedema <br/ ><br>2.AnorexiaTimepoint: 21 days
© Copyright 2025. All Rights Reserved by MedPath